Literature DB >> 16330996

Metal-on-metal total hip arthroplasty with large heads may prevent early dislocation.

Thomas M Smith1, Keith R Berend, Adolph V Lombardi, Roger H Emerson, Thomas H Mallory.   

Abstract

UNLABELLED: Postoperative dislocation is one of the major causes of morbidity and failure of total hip arthroplasty. We reviewed 327 patients (377 hips) retrospectively with varying diagnoses and indications but all of whom received large-diameter metal-on-metal prostheses. Two surgical approaches were used: the anterolateral abductor splitting (342 procedures) and a mini-incision posterior approach (35 procedures). Average age at time of surgery was 55.9 years and average followup was 4.0 months. There were 346 (91.8%) primary procedures, 15 (4.0%) conversion procedures, and 16 (4.2%) revisions or reimplantations. The most common preoperative diagnoses included osteoarthritis (250 hips; 66.3%) and avascular necrosis (46 hips; 12.2%). There were 62 (16.4%) patients with high-risk diagnoses for dislocation. The status in terms of postoperative dislocation was known for all patients. During the short followup period, there were no dislocations. Use of large-diameter femoral heads and metal-on-metal articulations decreases the risk of dislocations, making their use a viable choice for primary and revision procedures. LEVEL OF EVIDENCE: Therapeutic study, Level IV-1 (case series). See the Guidelines for Authors for a complete description of levels of evidence.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16330996     DOI: 10.1097/01.blo.0000193810.23706.73

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  19 in total

1.  Large-diameter metal-on-metal total hip arthroplasty: dislocation infrequent but survivorship poor.

Authors:  Adolph V Lombardi; Keith R Berend; Michael J Morris; Joanne B Adams; Michael A Sneller
Journal:  Clin Orthop Relat Res       Date:  2014-11-04       Impact factor: 4.176

2.  Low incidence of groin pain and early failure with large metal articulation total hip arthroplasty.

Authors:  John B Meding; Lindsey K Meding; E Michael Keating; Michael E Berend
Journal:  Clin Orthop Relat Res       Date:  2012-02       Impact factor: 4.176

3.  Do large heads enhance stability and restore native anatomy in primary total hip arthroplasty?

Authors:  Adolph V Lombardi; Michael D Skeels; Keith R Berend; Joanne B Adams; Orlando J Franchi
Journal:  Clin Orthop Relat Res       Date:  2011-06       Impact factor: 4.176

4.  Mid-term results of large diameter heads on cross-linked polyethylene liners in total hip replacement.

Authors:  Bhavesh Sachde; Nikunj D Maru
Journal:  J Clin Orthop Trauma       Date:  2012-10-17

5.  Ideal femoral head size in total hip arthroplasty balances stability and volumetric wear.

Authors:  Michael B Cross; Denis Nam; David J Mayman
Journal:  HSS J       Date:  2012-09-13

Review 6.  Total hip arthroplasty instability treatment without dual mobility cups: brief overview and experience of other options.

Authors:  Luigi Zagra; Eleonora Caboni
Journal:  Int Orthop       Date:  2017-01-14       Impact factor: 3.075

7.  The withdrawn ASR™ THA and hip resurfacing systems: how have our patients fared over 1 to 6 years?

Authors:  Kevin T Hug; Tyler S Watters; Thomas P Vail; Michael P Bolognesi
Journal:  Clin Orthop Relat Res       Date:  2013-02       Impact factor: 4.176

8.  What factors affect posterior dislocation distance in THA?

Authors:  Jim Nevelos; Aaron Johnson; Christopher Heffernan; James Macintyre; David C Markel; Michael A Mont
Journal:  Clin Orthop Relat Res       Date:  2013-02       Impact factor: 4.176

9.  Instability after total hip arthroplasty.

Authors:  Brian C Werner; Thomas E Brown
Journal:  World J Orthop       Date:  2012-08-18

10.  No difference in gait recovery after THA with different head diameters: a prospective randomized study.

Authors:  Luigi Zagra; Federica Anasetti; Luca Bianchi; Vittorio Licari; Roberto Giacometti Ceroni
Journal:  Clin Orthop Relat Res       Date:  2013-12       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.